Chronic obstructive pulmonary disease medical therapy
|
Chronic obstructive pulmonary disease Microchapters |
|
Differentiating Chronic obstructive pulmonary disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic obstructive pulmonary disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Chronic obstructive pulmonary disease medical therapy |
|
FDA on Chronic obstructive pulmonary disease medical therapy |
|
CDC on Chronic obstructive pulmonary disease medical therapy |
|
Chronic obstructive pulmonary disease medical therapy in the news |
|
Blogs on Chronic obstructive pulmonary disease medical therapy |
|
Directions to Hospitals Treating Chronic obstructive pulmonary disease |
|
Risk calculators and risk factors for Chronic obstructive pulmonary disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Philip Marcus, M.D., M.P.H. [2]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
Overview
Treatment of COPD requires a careful and thorough evaluation by a physician. The most important aspect of treatment is avoiding tobacco smoke and removing other air pollutants from the patient’s home or workplace. Symptoms such as coughing or wheezing can be treated with medication. Respiratory infections should be treated with antibiotics, if appropriate. Patients who have low blood oxygen levels in their blood are often given supplemental oxygen.
Medical therapy
- Treatment of COPD requires a careful and thorough evaluation by a physician.
- The most important aspect of treatment is avoiding tobacco smoke and removing other air pollutants from the patient’s home or workplace.
- Patients who have low blood oxygen levels in their blood are often given supplemental oxygen.
- Oral and inhaled medications are used for patients with stable chronic obstructive pulmonary disease (COPD) to reduce dyspnea, improve exercise tolerance, and prevent complications.
- Symptoms such as coughing or wheezing can be treated with bronchodilators like subcutaneous medications, beta-adrenergics, methylxanthines, and anticholinergics. They act via decreasing muscle tone in small and large airways in the lungs.
- Respiratory infections should be treated with antibiotics, if appropriate.
General therapy
- Treatment of COPD requires a careful and thorough evaluation by a physician.
- The most important aspect of treatment is avoiding tobacco smoke and removing other air pollutants from the patient’s home or workplace.
- Patients who have low blood oxygen levels in their blood are often given supplemental oxygen.
- Oral and inhaled medications are used for patients with stable chronic obstructive pulmonary disease (COPD) to reduce dyspnea, improve exercise tolerance, and prevent complications. Symptoms such as coughing or wheezing can be treated with bronchodilators like subcutaneous medications, beta-adrenergics, methylxanthines, and anticholinergics. They act via decreasing muscle tone in small and large airways in the lungs.
- Respiratory infections should be treated with antibiotics, if appropriate.
Beta adrenergic receptor agonists
Short acting selective B2 agonist
- Used for symptomatic relief during acute mild, exacerbation
- Mechanism of action - Increases intracellular cyclic adenosine monophosphate via activation of B2 -adrenergic receptors on smooth muscle cells of airway and causes smooth muscle relaxation.
- These agents are less effective in COPD compared to Asthma.
- Drugs available are:
Albuterol, Metaproterenol, Pirbuterol
- Used for bronchospasm refractory to epinephrine.
- Route - Inhaled
Levalbuterol
- Albuterol is a racemic mixture containing both R and S enantiomer. The S enantiomer doesn't bind to Beta 2 receptor and maybe the cause of side-effects. On the other hand, levalbuterol has only active R enantiomer thus causes less side-effects.
- It is used for both treatment and prevention of bronchospasm.
Long acting beta-2 adrenergic receptor agonist
- The long acting beta 2 receptor agonist are used to alleviate chronic persistent symptoms
- They help to increase exercise tolerance, prevent nocturnal dyspnea, and improve quality of life.
- Long-acting beta-agonists include salmeterol, formoterol, arformoterol, and indacaterol.
- They all require twice-daily dosing, except for indacaterol. Bronchodilating effect lasts more than 12 hours. Indacaterol is administered once daily.
Salmeterol, Formoterol, Arformoterol
- Relieve bronchospasms.
- Facilitate expectoration, improve symptoms and morning peak flows.
- Used in addition to anticholinergic agents.
Arformoterol
- Higher potency than racemic formoterol.
Indacaterol
- Indacaterol a long-acting beta2-agonist (LABA) is used for long-term, once-daily maintenance in patients with chronic obstructive pulmonary disease (COPD).
- It is not for use as initial therapy in patients with acute deteriorating COPD.